Dr Reddy’s Is Latest Player To Pivot To Trade Generics In India

Cipla, Torrent Among Firms Pushing Unbranded Generics In India Amid Headwinds

Dr Reddy’s Laboratories says it will work closely with its channel partners to ensure availability of its products, after entering into the unbranded, trade generics business in India with the launch of a new dedicated division, ‘RGenX’.

Indian flag
• Source: Shutterstock

Dr. Reddy's Laboratories is looking to further the company’s goal of reaching over 1.5 billion patients by 2030 after entering into the trade generics business in India with the launch of a new dedicated division, ‘RGenX’.

Moving forward, the Indian firm's branded medicines will be sold through the trade generics route, including a product brand name...

More from Generics

More from Products